These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 16981189

  • 21. Correlation of laterally spreading type and JC virus with methylator phenotype status in colorectal adenoma.
    Nosho K, Yamamoto H, Takahashi T, Mikami M, Hizaki K, Maehata T, Taniguchi H, Yamaoka S, Adachi Y, Itoh F, Imai K, Shinomura Y.
    Hum Pathol; 2008 May; 39(5):767-75. PubMed ID: 18284934
    [Abstract] [Full Text] [Related]

  • 22. DNA methylation in patients with colorectal cancer--correlation with some clinical and morphological features and with local tumour invasion.
    Mirchev MB, Kahl P, Friedrichs N, Kotzev IA, Buettner R.
    Folia Med (Plovdiv); 2010 May; 52(2):22-30. PubMed ID: 20836393
    [Abstract] [Full Text] [Related]

  • 23. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A, Niv Y, Nagasaka T, Morgenstern S, Levi Z, Fireman Z, Fuerst F, Goel A, Boland CR.
    Cancer; 2009 Feb 15; 115(4):760-9. PubMed ID: 19127559
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
    Bond CE, Umapathy A, Ramsnes I, Greco SA, Zhen Zhao Z, Mallitt KA, Buttenshaw RL, Montgomery GW, Leggett BA, Whitehall VL.
    Int J Cancer; 2012 Apr 01; 130(7):1567-76. PubMed ID: 21557216
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis.
    Fu T, Pappou EP, Guzzetta AA, Jeschke J, Kwak R, Dave P, Hooker CM, Morgan R, Baylin SB, Iacobuzio-Donahue CA, Wolfgang CL, Ahuja N.
    Clin Cancer Res; 2012 Sep 01; 18(17):4743-52. PubMed ID: 22825585
    [Abstract] [Full Text] [Related]

  • 32. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
    Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF.
    Inflamm Bowel Dis; 2011 Sep 01; 17(9):1966-70. PubMed ID: 21618350
    [Abstract] [Full Text] [Related]

  • 33. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
    Ogino S, Kawasaki T, Kirkner GJ, Ohnishi M, Fuchs CS.
    BMC Cancer; 2007 May 02; 7():72. PubMed ID: 17474983
    [Abstract] [Full Text] [Related]

  • 34. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C, Choi IS, Yao JC, Worah S, Xie K, Mansfield PF, Ajani JA, Rashid A, Hamilton SR, Wu TT.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
    Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS.
    J Mol Diagn; 2007 Jul 15; 9(3):305-14. PubMed ID: 17591929
    [Abstract] [Full Text] [Related]

  • 38. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA.
    Am J Surg Pathol; 2006 Dec 15; 30(12):1491-501. PubMed ID: 17122504
    [Abstract] [Full Text] [Related]

  • 39. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features.
    Ang PW, Loh M, Liem N, Lim PL, Grieu F, Vaithilingam A, Platell C, Yong WP, Iacopetta B, Soong R.
    BMC Cancer; 2010 May 21; 10():227. PubMed ID: 20492682
    [Abstract] [Full Text] [Related]

  • 40. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas.
    Judson H, Stewart A, Leslie A, Pratt NR, Baty DU, Steele RJ, Carey FA.
    J Pathol; 2006 Nov 21; 210(3):344-50. PubMed ID: 16902913
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.